Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Academic Drug Discovery

Malcolm Skingle's Biography

Malcolm Skingle, Director, Academic Liaison, GlaxoSmithKline

Malcolm Skingle has a BSc in Pharmacology/Biochemistry and a PhD in Neuropharmacology. He has worked in the pharmaceutical industry all of his working life and has gained a wide breadth of experience in the management of research activities. Part of his former role as a research leader in a Neuropharmacology department involved co-supervising collaborations with academics in the UK, Europe and USA. He has more than 60 publications including articles on the interface between industry and academia. Malcolm manages Academic Liaison at GSK with staff in Stevenage, Research Triangle Park and Philadelphia. His role involves close liaison with several groups outside the Company e.g. Government Departments, Research and Funding Councils, Small Biotechnology Companies and other science-driven organisations. He sits on many external bodies including several UK University Department advisory groups. He also chairs a number of groups including the Diamond (Synchotron) Industrial Advisory Board, the Cogent Science Industry Partnership Board driving skills for the life sciences sector and the ABPI group working on academic liaison. Malcolm has also been awarded a CBE in the 2009 Queen’s Birthday Honours List in recognition of his contribution to the pharmaceutical industry as well as an Honorary Professorship from the College of Medical and Dental Sciences at the University of Birmingham and an honorary DSc from the University of Hertfordshire and honorary degree from the University of Dundee and a fellowship from Imperial College London medical faculty. Malcolm was elected as a Fellow into the Faculty of Medicine at Imperial College London in 2011.

Malcolm Skingle Image

Industry Academic Relationships in a New Era of Drug Discovery

Monday, 6 March 2017 at 11:15

Add to Calendar ▼2017-03-06 11:15:002017-03-06 12:15:00Europe/LondonIndustry Academic Relationships in a New Era of Drug

Pharma and biotech are increasingly looking to universities for new ideas and technology to underpin their internal research efforts. This increase in activity had led to competition between the companies for academic inputs and a plethora of innovative models have been developed.

Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAcademic Drug